Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia (Q24634360)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q40289010)
(Q42834766)
(Q40001595)
(Q40001639)
(Q28421846)
(Q87712102)
(Q88032966)
(Q89295004)
(Q114455521)
(Q90948940)
(Q117224712)
(Q88034786)
(Q117224713)
(P304) 1033-41
(P407) (Q1860)
(P433) 3
(P478) 16
(P577) Monday, February 1, 2010
(P921) (Q42824440)
(P1433) (Q332253)
(P1476) "Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia" (language: en)
(P2093) Edie Weller
Nancy Rubin
Renee Leduc
Meghan Rourke
Xiaoying Jia
Diane Warren
Lyuba Varticovski
(P2860) (Q24634076)
(Q28252497)
(Q28272373)
(Q28244041)
(Q28237066)
(Q28201685)
(Q29615120)
(Q40093876)
(Q33375461)
(Q33374513)
(Q36461011)
(Q40328451)
(Q33369460)
(Q35914722)
(Q35692250)
(Q35577484)
(Q35116850)
(Q35116846)
(Q35116840)
(Q33964185)
(Q40702649)
(Q33940898)
(Q33810053)
(Q46131613)
(Q53876960)
(Q44079527)
(Q43706834)
(Q43539323)
(Q81583841)
(Q57905188)
other details
description scientific article

External Links